Br J Ophthalmol doi:10.1136/bjophthalmol-2011-301104
  • PostScript
  • Letter

A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis

  1. Shiu Ting Mak2
  1. 1Department of Ophthalmology, Union Hospital, Hong Kong
  2. 2Department of Ophthalmology, Caritas Medical Centre, Hong Kong
  1. Correspondence to Dr Albert Chak-ming Wong, Consultant Ophthalmologist, Union Hospital, 18 Fu Kin Street, Tai Wai, New Territories, Hong Kong; dralbertcmw{at}
  1. Contributors All authors contributed significantly to writing this letter.

  • Accepted 19 October 2011
  • Published Online First 3 November 2011

We read the article entitled ‘A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis’ by Wilkins and colleagues1 with great interest. Although viral conjunctivitis is typically a self-limiting disease that resolves in 2 weeks, we agree that an agent that reduces clinical symptoms and minimises shedding of infectious virus would be desirable given the morbidity and potential economic impact associated with an outbreak of viral conjunctivitis.2 We have the following observations regarding the methodology and interpretation of the results.

Eighty-eight out of 111 randomised patients returned for review, that is, …

No Related Web Pages

Register for free content

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article